PWRM, Power3 Medical Products Inc, PWRM.OB
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, PWRM has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Alzheimer's illness (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia of an Alzheimer's type (PDDAT), or Alzheimer's-is the most common sort of dementia. This unique incurable, degenerative, and deadly disorder was first explained German born professional as well as neuropathologist Alois Alzheimer in 1906 and was called after him. Most often, it really is determined in individuals over 65 years of age, although the less-prevalent early-onset Alzheimer's can take place much earlier. In 2006, there have been 26.6 million patients globally. Alzheimer's is predicted to threaten 1 in 85 people today worldwide by the year 2050
Cancer of the breast is a type of cancer where by cells within the breast separate and increase with out usual control. Pertaining to 85 % of breast cancers come from typically the mammary ducts, though about 15 per cent develop in the lobules. Tumors within the busts tend to mature slowly. As soon as a swelling can be big enough to help you feel, it may have already been developing for as long as 10 years. However, a few growths can be potent, and increase far more speedily.
Parkinson's disease typically has effects on people around fifty. The early signs of PD tend to be subtle and also occur gradually. When it comes to many people the condition moves along more rapidly than in others. The fact that the condition moves along, the shaking, or tremor, which will has an effect on nearly all PD individuals may turn to restrict every day actions. Other signs and symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been which can support in diagnosing sporadic PD. For that reason the medical diagnosis is determined by track record and a neurological examination. The illness can be tough to diagnose precisely. Physicians may very well sometimes demand brain scans or laboratory tests in order to exclude other diseases.
More about PWRM at www.Power3Medical.com
Cree, Inc. (Nasdaq:CREE) reported recently the industry’s first lighting-class LED array. The XLamp® CXA20 LED array is the first lighting-class array aimed at accelerating the LED lighting revolution and can enable a 60 watt A-lamp equivalent while consuming just 11 watts.
Cree, Inc. (Cree) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN) and related compounds. It focuses its expertise in SiC and GaN on light emitting diode (LED) products.
GRHU, GreenHouse Holdings, Inc., OTCQB:GRHU
GRHU is an integrator of some of the world’s most innovative environmental, public safety, infrastructure technologies. GRHU provides systems that are financially sound and sustainable to residential, commercial, and industrial and government markets around the globe.
GRHU recently reported the signing of multiple contract awards for its Life Protection (NYSE:LPI) Governmental Services Division, totaling $6 million. The recently acquired LPI subsidiary provides innovative training, support, design and construction of facilities and services to meet the needs of the U. S. Government, military, and law enforcement agencies.
GRHU has retained Rubenstein Public Relations to generate media exposure for the company’s efficient and environmentally sustainable innovations.
Furthermore, GRHU is completing the necessary steps to Up-List its shares to a senior U.S. stock exchange.
In order to facilitate the transition, GreenHouse established an independent board and appointed PKF, a nationally recognized accounting firm, as their SEC auditors
More about GRHU at www.greenhouseintl.com
Balchem Corporation (Nasdaq:BCPC) reported that its Board of Directors has declared a dividend on its shares of common stock equal to $0.15 per share, payable on January 20, 2011 to holders of record on December 21, 2010.
Douglas Dynamics, Inc. (NYSE:PLOW) reported that pursuant to the Company's dividend policy its board of directors has declared a quarterly cash dividend of $0.20 per share of the Company's common stock.
Douglas Dynamics is the North American leader in the design, manufacture and sale of snow and ice control equipment for light trucks, which consists of snowplows and sand and salt spreaders, and related parts and accessories
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB:GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.